Charlotte Andersson

492 total citations
7 papers, 302 citations indexed

About

Charlotte Andersson is a scholar working on Oncology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charlotte Andersson has authored 7 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Neurology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Charlotte Andersson's work include Lung Cancer Research Studies (3 papers), Neuroblastoma Research and Treatments (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Charlotte Andersson is often cited by papers focused on Lung Cancer Research Studies (3 papers), Neuroblastoma Research and Treatments (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Charlotte Andersson collaborates with scholars based in Sweden, France and United States. Charlotte Andersson's co-authors include J. Staffurth, Sten Nilsson, Lars Franzén, A Pecking, Patrick Olivier, A. Aksnes, S. Vasanthan, Peter Strang, Øyvind S. Bruland and Christine Carlsson‐Skwirut and has published in prestigious journals such as Scientific Reports, FEBS Letters and European Journal of Cancer.

In The Last Decade

Charlotte Andersson

7 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte Andersson Sweden 5 167 164 118 64 52 7 302
Abdulaziz Al‐Sugair Saudi Arabia 10 113 0.7× 65 0.4× 27 0.2× 38 0.6× 75 1.4× 21 326
Karen Geva Steinhoff Germany 9 100 0.6× 40 0.2× 65 0.6× 37 0.6× 45 0.9× 15 317
Laura Travascio Italy 10 163 1.0× 94 0.6× 37 0.3× 200 3.1× 16 0.3× 28 424
Ana Fröbe Croatia 9 52 0.3× 146 0.9× 56 0.5× 30 0.5× 55 1.1× 41 334
Kim M. Pabst Germany 10 119 0.7× 72 0.4× 200 1.7× 53 0.8× 51 1.0× 33 351
Maurizio Bellina Italy 6 108 0.6× 242 1.5× 183 1.6× 18 0.3× 44 0.8× 8 346
H.K. Tsai United States 3 35 0.2× 289 1.8× 71 0.6× 146 2.3× 38 0.7× 20 401
Maria Gebre‐Medhin Sweden 9 25 0.1× 122 0.7× 113 1.0× 96 1.5× 80 1.5× 18 371
Elizabeth Katherine Anna Triumbari Italy 9 117 0.7× 66 0.4× 49 0.4× 11 0.2× 33 0.6× 34 247
Katherine Clifton United States 10 55 0.3× 113 0.7× 194 1.6× 13 0.2× 80 1.5× 41 398

Countries citing papers authored by Charlotte Andersson

Since Specialization
Citations

This map shows the geographic impact of Charlotte Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Andersson more than expected).

Fields of papers citing papers by Charlotte Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Andersson. The network helps show where Charlotte Andersson may publish in the future.

Co-authorship network of co-authors of Charlotte Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Andersson. A scholar is included among the top collaborators of Charlotte Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Andersson. Charlotte Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Andersson, Charlotte, Amin Al-Awar, Emman Shubbar, et al.. (2023). Co-administration with A1M does not influence apoptotic response of 177Lu-octreotate in GOT1 neuroendocrine tumors. Scientific Reports. 13(1). 6417–6417. 1 indexed citations
2.
Andersson, Charlotte, et al.. (2020). Biodistribution of 131I in mice is influenced by circadian variations. Scientific Reports. 10(1). 15541–15541. 4 indexed citations
3.
Andersson, Charlotte, Emman Shubbar, Emil Schüler, et al.. (2019). Recombinant α1-Microglobulin Is a Potential Kidney Protector in 177Lu-Octreotate Treatment of Neuroendocrine Tumors. Journal of Nuclear Medicine. 60(11). 1600–1604. 12 indexed citations
4.
Nilsson, Sten, Peter Strang, A. Aksnes, et al.. (2012). A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. European Journal of Cancer. 48(5). 678–686. 191 indexed citations
5.
Hallqvist, Andreas, Fredrik Enlund, Charlotte Andersson, et al.. (2012). Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose Radiotherapy. PubMed. 2012. 1–6. 13 indexed citations
6.
Carlsson‐Skwirut, Christine, Charlotte Andersson, & Vicki R. Sara. (1987). Circulating forms of human foetal somatomedin. European Journal of Endocrinology. 114(1). 37–40. 4 indexed citations
7.
Carlsson‐Skwirut, Christine, Hans Jörnvall, Arne Holmgren, et al.. (1986). Isolation and characterization of variant IGF‐1 as well as IGF‐2 from adult human brain. FEBS Letters. 201(1). 46–50. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026